Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials

AIMS: Antithrombotic secondary prevention in stable cardiovascular disease (SCVD) patients at high ischemic risk remains unclear. We compared the efficacy and safety of aspirin monotherapy, clopidogrel monotherapy, ticagrelor monotherapy, rivaroxaban monotherapy, clopidogrel plus aspirin, ticagrelor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Houyong, Xu, Xiaoqun, Wang, Hanxin, Chen, Qilan, Fang, Xiaojiang, Zheng, Jianwu, Gao, Beibei, Tong, Guoxin, Zhou, Liang, Chen, Tielong, Huang, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869170/
https://www.ncbi.nlm.nih.gov/pubmed/36698936
http://dx.doi.org/10.3389/fcvm.2022.1040473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869170/
https://www.ncbi.nlm.nih.gov/pubmed/36698936
http://dx.doi.org/10.3389/fcvm.2022.1040473

Ejemplares similares